Diego Cadavid to Amyotrophic Lateral Sclerosis
This is a "connection" page, showing publications Diego Cadavid has written about Amyotrophic Lateral Sclerosis.
Connection Strength
0.810
-
Gontier G, Kim G, Wang C, Zhu K, Gau R, Zhang N, Naphade S, Stewart A, Schmidt MJ, Galemmo R, Shook B, Tarachandani A, Choi I, Raines S, Scannevin RH, Grievink HW, Smits LMG, Kremer PHC, Cadavid D. Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB): A Translational Pharmacodynamic Biomarker for PIKfyve Inhibition With VRG50635. Clin Transl Sci. 2026 02; 19(2):e70489.
Score: 0.647
-
Neumann M, Kothare H, Bartlett M, Roesler O, Suendermann-Oeft C, Hosamath A, Arbatti L, Pautler D, Suendermann-Oeft D, Cadavid D, Scannevin RH, Hoffmann I, Tarachandani A, Haley T, Raines S, Damme PV, Tienari P, Solje E, Jokela M, Genge A, O'Connell C, Eijk RPAV, Berg LHVD, Ramanarayanan V. Speech-based digital endpoints track ALS progression and align with standard clinical outcomes: evidence from the VRG50635 trial. Sci Rep. 2026 Apr 14; 16(1).
Score: 0.164